Change to read:
Identification
The retention time of the major peak in the chromatogram of the
Assay preparation corresponds to that in the chromatogram of the
Standard preparation, as obtained in the
Assay.
USP29
Assay
Mobile phase and Chromatographic system
Proceed as directed in the
Assay under
Dibucaine.
Standard preparation
Transfer about 55 mg of
USP Dibucaine Hydrochloride RS, accurately weighed, to a 50-mL volumetric flask, add 24.0 mL of 0.1 N hydrochloric acid, and swirl to dissolve. Dilute with a mixture of methanol and 1.0 N hydrochloric acid (13:12) to volume, and mix. Transfer 10.0 mL of this solution to a 50-mL volumetric flask, dilute with methanol to volume, and mix. Pass through a suitable filter having a 0.5-µm or finer porosity.
Assay preparation
Weigh accurately a portion of Ointment, equivalent to about 50 mg of dibucaine, transfer to a separator containing 50 mL of ether, and mix to dissolve. Extract successively with 50-mL, 40-mL, and 30-mL portions of 0.1 N hydrochloric acid, combining the extracts in a 250-mL volumetric flask. Dilute with methanol to volume, and mix. Pass through a suitable filter having a 0.5-µm or finer porosity.
Procedure
Separately inject equal volumes (about 10 µL) of the
Standard preparation and the
Assay preparation into the chromatograph, record the chromatograms, and measure the area responses for the major peaks. Calculate the quantity, in mg, of dibucaine (C
20H
29N
3O
2) in the portion of Ointment taken by the formula:
(343.46/379.93)(250C)(rU / rS)
in which 343.46 and 379.93 are the molecular weights of dibucaine and dibucaine hydrochloride, respectively;
C is the concentration, in mg per mL, of
USP Dibucaine Hydrochloride RS in the
Standard preparation; and
rU and
rS are the area responses of the dibucaine peaks obtained from the
Assay preparation and the
Standard preparation, respectively.